ReviewDigestive diseases and sciences2016

Cardiovascular Risk Reduction in Patients with Nonalcoholic Fatty Liver Disease: The Potential Role of Ezetimibe.

Tracey G Simon et al.PubMed ↗Publisher ↗

No numbers read from the abstract.